Biblio

Export 137 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
A. M. V. Wennberg, Gustafson, D., Hagen, C. E., Roberts, R. O., Knopman, D., Jack, C., Petersen, R. C., and Mielke, M. M., “Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 2, pp. 573-81, 2016.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
M. L. Werhane, Thomas, K. R., Edmonds, E. C., Bangen, K. J., Tran, M., Clark, A. L., Nation, D. A., Gilbert, P. E., Bondi, M. W., and Delano-Wood, L., “Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1567-1578, 2018.
C. Werner, Wiloth, S., Lemke, N. Christin, Kronbach, F., Jansen, C. - P., Oster, P., Bauer, J. M., and Hauer, K., “People with Dementia Can Learn Compensatory Movement Maneuvers for the Sit-to-Stand Task: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 1, pp. 107-120, 2017.
A. M. Wessels, Belger, M., Johnston, J. A., Yu, Y., Rentz, D. M., Dowsett, S. A., and Chandler, J., “Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.”, J Alzheimers Dis, vol. 88, no. 2, pp. 577-588, 2022.
P. S. J. Weston, Paterson, R. W., Dickson, J., Barnes, A., Bomanji, J. B., Kayani, I., Lunn, M. P., Mummery, C. J., Warren, J. D., Rossor, M. N., Fox, N. C., Zetterberg, H., and Schott, J. M., “Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?”, J Alzheimers Dis, vol. 54, no. 4, pp. 1297-1302, 2016.
S. Westwood, Leoni, E., Hye, A., Lynham, S., Khondoker, M. R., Ashton, N. J., Kiddle, S. J., Baird, A. L., Sainz-Fuertes, R., Leung, R., Graf, J., Hehir, C. Tan, Baker, D., Cereda, C., Bazenet, C., Ward, M., Thambisetty, M., and Lovestone, S., “Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.”, J Alzheimers Dis, vol. 52, no. 2, pp. 561-72, 2016.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
M. Wezyk, Szybinska, A., Wojsiat, J., Szczerba, M., Day, K., Ronnholm, H., Kele, M., Berdynski, M., Peplonska, B., Fichna, J. Piotr, Ilkowski, J., Styczyńska, M., Barczak, A., Zboch, M., Filipek-Gliszczyńska, A., Bojakowski, K., Skrzypczak, M., Ginalski, K., Kabza, M., Makalowska, I., Barcikowska-Kotowicz, M., Wojda, U., Falk, A., and Zekanowski, C., “Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 1, pp. 175-202, 2018.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
B. White, Lyketsos, C. G., Rosenberg, P. B., Oh, E. S., and Chen, L., “Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1383-1387, 2021.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
L. R. White, Corrada, M. M., Kawas, C. H., Cholerton, B. A., Edland, S. E., Flanagan, M. E., and Montine, T. J., “Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.”, J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
H. E. Whitson, Potter, G. G., Feld, J. A., Plassman, B. L., Reynolds, K., Sloane, R., and Welsh-Bohmer, K. A., “Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1137-1148, 2018.
P. Wijesinghe, Shankar, S. K., Yasha, T. C., Gorrie, C., Amaratunga, D., Hulathduwa, S., K Kumara, S., Samarasinghe, K., Suh, Y. - H., Steinbusch, H. W. M., and K De Silva, R. D., “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
E. H. Wilker, Martinez-Ramirez, S., Kloog, I., Schwartz, J., Mostofsky, E., Koutrakis, P., Mittleman, M. A., and Viswanathan, A., “Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1315-23, 2016.
H. M. Wilkins, Mahnken, J. D., Welch, P., Bothwell, R., Koppel, S., Jackson, R. L., Burns, J. M., and Swerdlow, R. H., “A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.”, J Alzheimers Dis, vol. 59, no. 1, pp. 291-300, 2017.
H. M. Wilkins, Troutwine, B. R., Menta, B. W., Manley, S. J., Strope, T. A., Lysaker, C. R., and Swerdlow, R. H., “Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion.”, J Alzheimers Dis, vol. 85, no. 1, pp. 381-394, 2021.
E. A. J. Willemse, Durieux-Lu, S., van der Flier, W. M., Pijnenburg, Y. A. L., de Jonge, R., and Teunissen, C. E., “Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 107-16, 2016.
K. Willén, Sroka, A., Takahashi, R. H., and Gouras, G. K., “Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.”, J Alzheimers Dis, vol. 60, no. 2, pp. 511-524, 2017.
S. M. Williams, Schulz, P., Rosenberry, T. L., Caselli, R. J., and Sierks, M. R., “Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 23-35, 2017.
E. N. Wilson, Carmo, S. Do, Welikovitch, L. A., Hall, H., Aguilar, L. Flores, Foret, M. K., M Iulita, F., Jia, D. Tong, Marks, A. R., Allard, S., Emmerson, J. T., Ducatenzeiler, A., and A Cuello, C., “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
A. Wimo, “The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.”, J Alzheimers Dis, 2018.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.

Pages